As healthcare moves toward genetically tailored treatments, one of the biggest hurdles to truly personalized medicine is the lack of fast, low-cost genetic testing. And few people are more familiar with the problems of today’s genetic diagnostics tools than Kalim Mir, the 52-year-old founder of XGenomes, who has spent his entire professional career studying the […]
View More XGenomes is bringing DNA sequencing to the massesCategory: genomics
Healthcare by 2028 will be doctor-directed, patient-owned and powered by visual technologies
Evan Nisselson Contributor Evan Nisselson is a partner at LDV Capital. More posts by this contributor Deep learning with synthetic data will democratize the tech industry The war over artificial intelligence will be won with visual data Visual assessment is critical to healthcare – whether that is a doctor peering down your throat as you […]
View More Healthcare by 2028 will be doctor-directed, patient-owned and powered by visual technologiesDriving down the cost of preserving genetic material, Acorn Biolabs raises $3.3 million
Acorn Biolabs wants consumers to pay them to store genetic material in a bet that the increasing advances in targeted genetic therapies will yield better healthcare results down the line. The company’s pitch is to “Save young cells today, live a longer, better, tomorrow.” It’s a gamble on the frontiers of healthcare technology that has managed […]
View More Driving down the cost of preserving genetic material, Acorn Biolabs raises $3.3 millionSophia Genetics bags $77M Series E, with 850+ hospitals signed up to its “data-driven medicine”
Another sizeable cash injection for big data biotech: Sophia Genetics has announced a $77M Series E funding round, bringing its total raised to $140M since the business was founded back in 2011. The company, which applies AI to DNA sequencing to enable what it dubs “data-driven medicine”, last closed a $30M Series D in fall 2017. […]
View More Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its “data-driven medicine”DeepMind claims early progress in AI-based predictive protein modelling
Google -owned AI specialist, DeepMind, has claimed a “significant milestone” in being able to demonstrate the usefulness of artificial intelligence to help with the complex task of predicting 3D structures of proteins based solely on their genetic sequence. Understanding protein structures is important in disease diagnosis and treatment, and could improve scientists’ understanding of the human […]
View More DeepMind claims early progress in AI-based predictive protein modellingAgtech startup Imago AI is using computer vision to boost crop yields
Presenting onstage today in the 2018 TC Disrupt Berlin Battlefield is Indian agtech startup Imago AI, which is applying AI to help feed the world’s growing population by increasing crop yields and reducing food waste. As startup missions go, it’s an impressively ambitious one. The team, which is based out of Gurgaon near New Delhi, […]
View More Agtech startup Imago AI is using computer vision to boost crop yieldsThe genomics-focused Illumina Accelerator backs five new companies
Illumina Accelerator, the genomics-focused startup accelerator backed by the publicly traded genetic sequencing pioneer Illumina Corp., has picked five startups for its seventh accelerator class, the company announced. Wth technology addressing skin microbial therapeutics, fertility science, chronic disease alleviation, post traumatic stress disorder treatments, and services for the biopharmaceutical and clinical research industries; the startups […]
View More The genomics-focused Illumina Accelerator backs five new companiesIs America’s national security Facebook and Google’s problem?
Jamie Metzl Contributor Share on Twitter Jamie Metzl is a Senior Fellow for Technology and National Security at the Atlantic Council. More posts by this contributor Homo Sapiens 2.0? We need a species-wide conversation about the future of human genetic enhancement Eleonore Pauwels Contributor Share on Twitter Eleonore Pauwels is Director of the Anticipatory Intelligence […]
View More Is America’s national security Facebook and Google’s problem?Human sequencing pioneer George Church wants to give you the power to sell your DNA on the blockchain
The blockchain is the buzziest thing on the internet these days and now MIT professor and godfather of the Human Genome Project George Church wants to put your genes on it.
His new startup Nebula Genomics plans to sequence your genome for under $1,000 (the current going rate of whole genome sequencing) and then add your data to the blockchain through the purchase of a “Nebula… Read More